Work of the WIN consortium and challenges of personalised cancer therapy
Work of the WIN consortium and challenges of personalised cancer therapy
Tumour-infiltrating immune cells as classifiers and predictors of outcome
Molecular investigations of immune cells and tumour environment: The ovarian cancer model
Combining immunological and targeted agents in melanoma
microRNA replacement in malignant pleural mesothelioma
Personalised cancer medicine using the human protein atlas and affibodies
ARC Foundation's work and aims
EORTC fosters move towards tailored cancer treatment through the SPECTA initiative in colorectal cancer
ecancermedicalscience editor's choice for June 2014
Retinoic acid in acute promyelocytic leukaemia as alternative to chemotherapy
Gdf -11 a new target to improve anaemia in thalassemia
Biomarkers in CLL prognosis